willdate
First patient enrolled in study of integrated laser atherectomy and IVL...
Royal Philips has announced enrolment of the first patient in the US THOR IDE clinical trial, which will study an innovative combined laser atherectomy...
TCT 2024: PATCH study reports initial positive results for sutureless vascular...
Vivasure Medical has announced initial positive results from its US IDE PATCH pivotal study evaluating the safety and efficacy of the Vivasure PerQseal closure...
One-year results confirm safety and efficacy results of conformable AAA device...
Results of a sub-study from the pivotal Investigational Device Exemption (IDE) trial assessing Gore’s Excluder conformable abdominal aortic aneurysm (AAA) endoprosthesis have shown...
Abbott’s Esprit BTK scaffold system given US FDA approval for CLTI...
Abbott has announced that the US Food and Drug Administration (FDA) has approved the Esprit BTK everolimus-eluting resorbable scaffold system (Esprit BTK system), a...
Johnson & Johnson to acquire Shockwave Medical
Johnson & Johnson is to acquire Shockwave Medical, it has been announced today.
Under the terms of the transaction, Johnson & Johnson will acquire all...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and...
Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) recent change of position on the use of paclitaxel-coated devices...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk...
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...